Diffuse Parenchymal Lung Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2017-04-13
Clinical Trial Update: The Clinical Value of Serum KL-6 Changes on Evaluating Disease Development in Different Diffuse Parenchymal Lung Disease
This clinical trial update evaluates whether changes in the serum biomarker KL-6 can help evaluate disease development across different diff…